Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Peter Probst"'
Autor:
Peter Probst, Kevin Green, Huyen Dinh, Francisco Zapata, Darbie Whitman, Tom Graddis, Myriam Bouchlaka, Meghan Zuck, Ray Fox, Tatyana Pisarenko, Elsa L Hay, Gajendra Naika, Jacob Heit, Kamal D Puri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/225f7329d1174f1fadd5a0bc6fd5c886
Autor:
Peter Probst, Kevin Green, Huyen Dinh, Francisco Zapata, Darbie Whitman, Tom Graddis, Meghan Zuck, Ray Fox, Myriam N Bouchlaka, Tatyana Pisarenko, Elsa L Hay, Gajendra Naika, Jacob Heit, Kamal D Puri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c3b2b6e20b1c43349d3d7d553ad93c77
Autor:
Lauren Loh, Peter Probst, Huyen Dinh, Sam Lam, Valerie Wall, Francisco Zapata, Darbie Whitman, Ramya Chandrasekaran, Texia Loh, Tom Graddis, Myriam Bouchlaka
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/f75ff5ac7dcb4b2cb117acb7f1f07ddb
Autor:
Peter Probst, Huyen Dinh, Sam Lam, Valerie Wall, Darbie Whitman, Tom Graddis, Myriam Bouchlaka, Randi Simmons, Meghan Zuck, Ray Fox, Kamal Puri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/0bec906e607e4397b8846563cc9eb68c
Autor:
Lauren Loh, Peter Probst, Huyen Dinh, Sam Lam, Valerie Wall, Francisco Zapata, Ramya Chandrasekaran, Texia Loh, Tom Graddis, Myriam Bouchlaka, Meghan Zuck, Kamal Puri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/0bf239d98c2d42febf9ca9dde79bd852
Autor:
Meghan Zuck, Myriam Bouchlaka, Huyen Dinh, Kevin Green, Meilyn Sylvestre, Francisco Zapata, Ramya Chandrasekaran, Gajendra Naika, Lauren Loh, Ray Fox, Darbie Whitman, Tom Graddis, Kamal Puri, Peter Probst
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::475894f6b3a618e3af1f122111e870e9
https://doi.org/10.1136/jitc-2022-sitc2022.0498
https://doi.org/10.1136/jitc-2022-sitc2022.0498
Autor:
Eric J Tarcha, Chelsea M Olsen, Peter Probst, David Peckham, Ernesto J Muñoz-Elías, James G Kruger, Shawn P Iadonato
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180762 (2017)
Dalazatide is a specific inhibitor of the Kv1.3 potassium channel. The expression and function of Kv1.3 channels are required for the function of chronically activated memory T cells, which have been shown to be key mediators of autoimmune diseases,
Externí odkaz:
https://doaj.org/article/f137890bf7c24d3ebf96fb3d4a62b3ef
Autor:
Meghan Zuck, Myriam Bouchlaka, Huyen Dinh, Kevin Green, Francisco Zapata, Ramya Chandrasekaran, Tatyana Pisarenko, Lauren Loh, Gajendra S. Naika, Meilyn Sylvestre, Jacob Heit, Raymond Fox, Darbie Whitman, Tom Graddis, Kamal D. Puri, Peter Probst
Publikováno v:
Cancer Research. 83:6376-6376
Background: One cause for the failure of checkpoint inhibitors is the immunosuppressive nature of the tumor microenvironment. LILRB1 (ILT2) and LILRB2 (ILT4) are ITIM-containing inhibitory receptors that recognize HLA Class 1 and nonclassical ligands
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dde445586a313b89eac75267d6877089
https://doi.org/10.1158/1538-7445.am2023-6376
https://doi.org/10.1158/1538-7445.am2023-6376